Latest news

Gilead Sciences Newly Approved HCV Drug Priced Significantly Lower than Other HCV Treatments

June 29, 2016 at 11:11 am

Research-based biopharmaceutical company Gilead Sciences (GILD) has priced it newly approved hepatitis C treatment drug Epclusa at $74,760 for a 12-week course of treatment, according to Gilead’s chief executive officer, John Milligan, in an interview by Bloomberg. The company had earlier announced the U.S. Food and Drug Administration (FDA) hadRead More

Nordstrom’s Trunk Club To Close Goose Island Facility

June 29, 2016 at 11:10 am

Fashion specialty retailer Nordstrom (JWN) said Tuesday that it is planning to close Trunk Club fulfillment center located on Goose Island in Chicago, Illinois. With the closing, Trunk Club will integrate its operations into the Nordstrom network of fulfillment and distribution centers, located across the United States. The Goose IslandRead More

Aflac Subsidiaries’ Outlook Revised to Negative by Fitch Ratings

June 16, 2016 at 10:07 pm

Aflac (AFL) shares were slightly lower on Thursday after Fitch Ratings revised the rating outlook for the health and life insurance firm’s subsidiaries to negative, while the rating outlook for the holding company is stable. The ratings agency also affirmed Aflac’s issuer default rating at ‘A’ and the senior debtRead More

Netflix to Premiere Genius Brands International’s Preschool Series “Llama Llama”

June 16, 2016 at 10:03 pm

Netflix (NFLX) said Thursday it will premier Genius Brands International’s pre-school series, Llama Llama, to its global subscribers in 2017. ¬†Currently in production on 15 half-hour episodes, Llama Llama is based on the award-winning and bestselling book series by author and illustrator Anna Dewdney, according to a statement Thursday. ItRead More